Skip to main content

Assenagon Asset Management S.A.

Source: SEC Form 13F · as of Mar 2026

Assenagon Asset Management S.A. holds 52 biotech & pharma companies tracked by BioSniper, totaling $1.13B in value as of Mar 2026 (SEC Form 13F).

Companies held

52

Total value held

$1.13B

BioSniper AIPage evidence connected

Prepared research question

What matters most for Roivant Sciences Ltd. (ROIV)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
ROIVRoivant Sciences Ltd.7,076,488$196.0M
REGNREGENERON PHARMACEUTICALS, INC.207,788$160.5M
AXSMAxsome Therapeutics, Inc.865,958$146.4M
BMRNBIOMARIN PHARMACEUTICAL INC1,920,658$108.5M
GILDGILEAD SCIENCES, INC.512,436$71.4M
PCVXVaxcyte, Inc.1,164,813$67.7M
JAZZJazz Pharmaceuticals plc320,000$60.5M
ALNYALNYLAM PHARMACEUTICALS, INC.128,896$42.6M
TEVATeva Pharmaceutical Industries Limited1,339,702$40.4M
IRONDisc Medicine, Inc.546,247$34.9M
STOKStoke Therapeutics, Inc.907,015$29.5M
SUPNSUPERNUS PHARMACEUTICALS, INC.530,618$27.4M
ZYMEZymeworks Inc.727,986$18.2M
TGTXTG THERAPEUTICS, INC.510,054$16.9M
COGTCogent Biosciences, Inc.295,650$11.4M
ARGXARGENX SE14,786$10.8M
INVAInnoviva, Inc.444,222$10.4M
INSMINSMED Inc63,259$10.3M
RGNXREGENXBIO Inc.980,611$8.2M
EXELEXELIXIS, INC.137,080$5.9M
IMVTImmunovant, Inc.205,219$5.1M
ORGOOrganogenesis Holdings Inc.1,967,952$4.7M
CLDXCelldex Therapeutics, Inc.146,525$4.6M
PTCTPTC THERAPEUTICS, INC.61,397$4.2M
ARWRARROWHEAD PHARMACEUTICALS, INC.58,735$3.7M
BBIOBridgeBio Pharma, Inc.44,092$3.3M
KURAKura Oncology, Inc.339,712$2.8M
IONSIONIS PHARMACEUTICALS INC33,673$2.5M
QUREuniQure N.V.146,749$2.4M
AGIOAGIOS PHARMACEUTICALS, INC.67,153$2.3M
CGEMCullinan Therapeutics, Inc.138,705$2.0M
RDYDR REDDYS LABORATORIES LTD137,020$1.9M
ACADACADIA PHARMACEUTICALS INC78,127$1.7M
CTMXCytomX Therapeutics, Inc.364,173$1.7M
ANIPANI PHARMACEUTICALS INC15,897$1.2M
SMMTSummit Therapeutics Inc.59,621$1.1M
SYRESpyre Therapeutics, Inc.18,647$941K
CRBPCorbus Pharmaceuticals Holdings, Inc.85,246$800K
INCYIncyte Corp.8,357$787K
FDMT4D Molecular Therapeutics, Inc.83,333$776K
PRTAPROTHENA CORP PUBLIC LTD CO76,769$746K
OPKOPKO HEALTH, INC.652,066$740K
OVIDOvid Therapeutics Inc.227,742$506K
OCULOCULAR THERAPEUTIX, INC45,600$386K
RCKTRocket Pharmaceuticals Inc.99,026$355K
ARVNARVINAS, INC.28,736$305K
HROWHARROW, INC.7,502$265K
TVTXTravere Therapeutics, Inc.7,927$236K
FATEFATE THERAPEUTICS INC190,252$228K
IOVAIOVANCE BIOTHERAPEUTICS, INC.46,842$164K
CRDFCardiff Oncology, Inc.67,231$109K
SPROSpero Therapeutics, Inc.18,636$44K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.